FUNCTIONAL AREAS – Page 78

Internal audit findings ignored during remediation – preventing repeat observations

Recognizing symptoms or signals indicative of ignored internal audit findings is the first step in initiating an investigation. Common signals may include:Click to read the full article.

Management review ineffective during mock audit – preventing repeat observations

Identifying the early warning signals of an ineffective management review is critical. Symptoms can manifest at various levels, including:Click to read the full article.

Management review ineffective during corporate review – evidence pack for inspectors

Identifying symptoms of ineffective management reviews is the first essential step in the investigation process. These signals might include:Click to read the full article.

Global SOP harmonization gaps during corporate review – CAPA program design

Identifying symptoms of harmonization gaps typically begins in two primary areas: the manufacturing floor and laboratory settings. Key signals may include inconsistencies in training documentation, discrepancies in SOP execution, and…

Global SOP harmonization gaps during remediation – preventing repeat observations

Identifying symptoms of SOP harmonization gaps is the first step in initiating an effective investigation. These signals can manifest in various forms, including but not limited to:Click to read the…

Compliance gaps not escalated during corporate review – evidence pack for inspectors

Addressing Compliance Gaps Not Escalated During Corporate Review: An Investigation Approach During corporate reviews, unaddressed compliance gaps can jeopardize regulatory standing and operational integrity. This article outlines an effective investigation…

Management review ineffective during corporate review – how to satisfy FDA/EMA expectations

Identifying symptoms or signals indicating ineffective management reviews is crucial for early detection and intervention. These symptoms can manifest in various forms:Click to read the full article.

Third-party oversight failure during corporate review – CAPA program design

The initial step in diagnosing a third-party oversight failure is recognizing the symptoms or signals within your operations. Common indicators may include:Click to read the full article.

Inspection readiness untested during enforcement response – evidence pack for inspectors

Ensuring Inspection Readiness in the Face of Enforcement Response Challenges In the pharmaceutical industry, regulatory inspections are critical for ensuring compliance with Good Manufacturing Practices (GMP). When enforcement actions arise,…

Management review ineffective before regulatory inspection – how to satisfy FDA/EMA expectations

Recognition of symptoms is the first step in addressing issues related to management reviews. Signals indicating potential ineffectiveness include:Click to read the full article.

Internal audit findings ignored before regulatory inspection – CAPA program design

Recognizing the early symptoms of ignored audit findings is paramount in mitigating compliance risks. Common signals in the manufacturing environment that may indicate systemic issues include:Click to read the full…

Inspection readiness untested before regulatory inspection – how to satisfy FDA/EMA expectations

Identifying symptoms or signals that indicate a potential issue is the cornerstone of effective investigation. Here are some common signals to monitor within the manufacturing and quality control environments:Click to…